Cargando…

PARP inhibitors are not all equal

To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair.(1)(,)(2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP r...

Descripción completa

Detalles Bibliográficos
Autor principal: Dent, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926879/
https://www.ncbi.nlm.nih.gov/pubmed/24025256
http://dx.doi.org/10.4161/cbt.26160
_version_ 1782304033832173568
author Dent, Paul
author_facet Dent, Paul
author_sort Dent, Paul
collection PubMed
description To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair.(1)(,)(2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP ribosylates itself and other proteins. PARP facilitates DNA repair complex formation, e.g., with BRCA1/2, and the activation of the cell cycle regulatory enzymes ATM and ATR.(2) PARP inhibitors as a single agent have only shown any degree of efficacy in breast and ovarian cancer patients who lack BRCA1/2 function.(3)(,)(4) The present studies examined PARP1 inhibitor biology in a range of triple negative and non-triple negative breast cancer cell lines.
format Online
Article
Text
id pubmed-3926879
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-39268792014-02-26 PARP inhibitors are not all equal Dent, Paul Cancer Biol Ther Commentary To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair.(1)(,)(2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP ribosylates itself and other proteins. PARP facilitates DNA repair complex formation, e.g., with BRCA1/2, and the activation of the cell cycle regulatory enzymes ATM and ATR.(2) PARP inhibitors as a single agent have only shown any degree of efficacy in breast and ovarian cancer patients who lack BRCA1/2 function.(3)(,)(4) The present studies examined PARP1 inhibitor biology in a range of triple negative and non-triple negative breast cancer cell lines. Landes Bioscience 2013-10-01 2013-08-26 /pmc/articles/PMC3926879/ /pubmed/24025256 http://dx.doi.org/10.4161/cbt.26160 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Commentary
Dent, Paul
PARP inhibitors are not all equal
title PARP inhibitors are not all equal
title_full PARP inhibitors are not all equal
title_fullStr PARP inhibitors are not all equal
title_full_unstemmed PARP inhibitors are not all equal
title_short PARP inhibitors are not all equal
title_sort parp inhibitors are not all equal
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926879/
https://www.ncbi.nlm.nih.gov/pubmed/24025256
http://dx.doi.org/10.4161/cbt.26160
work_keys_str_mv AT dentpaul parpinhibitorsarenotallequal